Evidence map›Paper›PMID 28259047›Full record

ArticleVirology2017

The tripartite leader sequence is required for ectopic expression of HAdV-B and HAdV-E E3 CR1 genes.

Camden R Bair, Poornima Kotha Lakshmi Narayan, Adriana E Kajon

Open access · greenAbstract read
In one paragraph

Article in Virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Camden R BairInfectious Disease Program, Lovelace Respiratory Research Institute, Albuquerque, NM, United States.
Poornima Kotha Lakshmi NarayanInfectious Disease Program, Lovelace Respiratory Research Institute, Albuquerque, NM, United States.
Adriana E KajonInfectious Disease Program, Lovelace Respiratory Research Institute, Albuquerque, NM, United States. Electronic address: akajon@lrri.org.
Lovelace Respiratory Research Institute · US

Funding

Biology of Infectious Diseases &InflammationT32AI007538 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Michelle A Ozbun · 1998 to 2026
$5.2M
NIAID NIH HHS T32 AI007538
6 · The paper itself

Abstract

The unique repertoire of genes that characterizes the early region 3 (E3) of the different species of human adenovirus (HAdV) likely contributes to their distinct pathogenic traits. The function of many E3 CR1 proteins remains unknown possibly due to unidentified intrinsic properties that make them difficult to express ectopically. This study shows that the species HAdV-B- and HAdV-E-specific E3 CR1 genes can be expressed from vectors carrying the HAdV tripartite leader (TPL) sequence but not from traditional mammalian expression vectors. Insertion of the TPL sequence upstream of the HAdV-B and HAdV-E E3 CR1 open reading frames was sufficient to rescue protein expression from pCI-neo constructs in transfected 293T cells. The detection of higher levels of HAdV-B and HAdV-E E3 CR1 transcripts suggests that the TPL sequence may enhance gene expression at both the transcriptional and translational levels. Our findings will facilitate the characterization of additional AdV E3 proteins.

Indexed as

5' Untranslated RegionsAdenovirus E3 ProteinsAdenoviruses, HumanEctopic Gene ExpressionElectroporationGenetic VectorsGenome, ViralHEK293 CellsHeLa CellsHumansMicroscopy, FluorescenceOpen Reading FramesProtein Sorting SignalsTransfectionViral Proteins5' Untranslated RegionsAdenovirus E3 ProteinsProtein Sorting SignalsViral ProteinsCR1 genesEarly region 3Human adenoviruspMT2Tripartite leader sequence

Identifiers

PMID28259047
PMCPMC7444620
OpenAlexW2593691683

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.